FDG-PET may aid treatment decisions for prostate cancer

07/2/2013 | Renal and Urology News

A study presented at a urological meeting found that in patients with prostate cancer, FDG uptake by the prostate as seen on PET scans may be useful for determining whether to treat with radical prostatectomy. "Since there is a high failure rate with prostatectomy, the presence or absence of FDG uptake can help you decide whether to still do a radical prostatectomy in a morbid patient or just reorient the patient to radiation therapy or androgen deprivation therapy," said lead researcher Dr. Frederic Pouliot from Laval University in Quebec. The team compared results from FDG-PET imaging with those from surgery.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA